{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:33Z","timestamp":1792831053069,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110579","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:01:21Z","timestamp":1790348481000},"page":"110579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, mechanistic evaluation, and in silico study of pyrimidine-coumarin hybrids as promising anticancer agents"],"prefix":"10.1016","volume":"183","author":[{"given":"R.","family":"Vinay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar G.","family":"Alegaon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Basavaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niteen R.","family":"Sutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Gudasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas R.","family":"Mathad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N. Chethan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen A.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.110579_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110579_bb0010","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ajpath.2017.03.016","article-title":"The spectrum of triple-negative breast disease","volume":"187","author":"Geyer","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110579_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"issue":"36","key":"10.1016\/j.bioorg.2026.110579_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202505785","article-title":"EGFR: new insights on its activation and mutation in tumor and tumor immunotherapy","volume":"12","author":"Gu","year":"2025","journal-title":"Adv. Sci."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110579_bb0025","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.3390\/ijms26157065","article-title":"Design, synthesis, and anticancer evaluation of new small-molecule EGFR inhibitors targeting NSCLC and breast cancer","volume":"26","author":"Sever","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110579_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118146","article-title":"A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer","volume":"123","author":"Gawli","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110579_bb0035","article-title":"Overcoming resistance to osimertinib by T790M loss and C797S acquisition using gefitinib in a patient with EGFR-mutant NSCLC: A case report","volume":"4","author":"Enrico","year":"2023","journal-title":"TO Clin. Res. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110579_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020299","article-title":"Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110579_bb0045","doi-asserted-by":"crossref","DOI":"10.2174\/0115701638376725250619201905","article-title":"Diverse biological activity of pyrimidine derivatives: a review","volume":"23","author":"Anjali","year":"2026","journal-title":"Curr. Drug Discov. Technol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110579_bb0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/cbdd.14124","article-title":"Pyrimidine derivatives as EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: A comprehensive review","volume":"100","author":"Kizhakkedath Ratheesh","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110579_bb0055","doi-asserted-by":"crossref","first-page":"19205","DOI":"10.1021\/acs.jmedchem.5c01320","article-title":"Discovery of potent and selective Pyrrolo[2,3- d ]pyrimidine derivatives as fourth-generation EGFR inhibitors targeting triple mutations","volume":"68","author":"Wu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110579_bb0060","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1007\/s11030-024-11048-8","article-title":"Design, synthesis and antitumour activity of pyrimidine derivatives as novel selective EGFR kinase inhibitors","volume":"29","author":"Zhang","year":"2025","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110579_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/17460441.2024.2322990","article-title":"Molecular hybridization: a powerful tool for multitarget drug discovery","volume":"19","author":"de Sena Murteira Pinheiro","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110579_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.4696","article-title":"Recent perspectives on anticancer potential of coumarin against different human malignancies: an updated review","volume":"13","author":"Shahbaz","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.bioorg.2026.110579_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116179","article-title":"Anticancer mechanism of coumarin-based derivatives","volume":"267","author":"Yadav","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110579_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137790","article-title":"Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: synthesis, molecular modeling, TrkA, PI3K\/AKT and EGFR inhibition","volume":"1305","author":"Batran","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110579_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107682","article-title":"Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET\/STAT-3 inhibitors for potential antitumor agents","volume":"151","author":"Naguib","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110579_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117322","article-title":"Antiproliferative activity of selenium-enriched coumarin derivatives on the SK-N-SH neuroblastoma cell line: mechanistic insights","volume":"286","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110579_bb0095","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110579_bb0100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bmcl.2013.12.095","article-title":"Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents","volume":"24","author":"Zhang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110579_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s44174-026-00665-6","article-title":"Eco-friendly copper nanoparticles synthesized from Andrographis paniculata: a potential agent against breast cancer","author":"Cheriyan","year":"2026","journal-title":"Biomed. Mater. Devices"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110579_bb0110","article-title":"Repurposing baricitinib and\/or rosuvastatin to reinvigorate the anticancer immune response via suppressing PD-1\/PD-L1 and CTLA-4 inhibitory immune checkpoints and correlated oncogenic pathways in lung cancer models","volume":"12","author":"El-Hanboshy","year":"2026","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110579_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2026.103157","article-title":"Synthesis and evaluation of quinoline\u2013quinazoline hybrids as potential EGFR inhibitors","volume":"23","author":"Kavalapure","year":"2026","journal-title":"Results Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110579_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s13205-020-2088-7","article-title":"Functionalization of iron oxide nanoparticles with clove extract to induce apoptosis in MCF-7 breast cancer cells","volume":"10","author":"Thenmozhi","year":"2020","journal-title":"3 Biotech"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110579_bb0125","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1021\/acsomega.3c09578","article-title":"Multifaceted anticancer potential of Gnidia glauca (Fresen.) Gilg leaf alkaloids: impact on multiple cellular targets","volume":"9","author":"Valleti","year":"2024","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110579_bb0130","first-page":"2283","article-title":"Anti-cancer potential of Moringa oleifera leaves methanol extract: an in vitro study","volume":"54","author":"Umme Umaima","year":"2025","journal-title":"Cuest. Fisioter."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110579_bb0135","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1080\/14786419.2024.2445205","article-title":"Development of marker-based quantification methods for Diospyros montana Roxb using DoE approach and in-silico anti-diabetic screening of selected phytoconstituents of the Diospyros genus","volume":"40","author":"Kambalyal","year":"2026","journal-title":"Nat. Prod. Res."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110579_bb0140","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110579_bb0145","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00894-014-2191-y","article-title":"Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8","volume":"20","author":"Kalva","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bioorg.2026.110579_bb0150","series-title":"In Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing - SC \u201906","first-page":"84","article-title":"Molecular dynamics---scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.bioorg.2026.110579_bb0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.compbiolchem.2018.03.001","article-title":"Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: molecular docking and MM\/GBSA studies","volume":"74","author":"G\u00e1lvez","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110579_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116939","article-title":"Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione\u2019s in fructose induced insulin resistant rats","volume":"280","author":"Ranade","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110579_bb0165","series-title":"QikProp","author":"Schr\u00f6dinger Release 2025-4","year":"2025"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:07:14Z","timestamp":1792829234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0045206826011156"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110579","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, mechanistic evaluation, and in silico study of pyrimidine-coumarin hybrids as promising anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110579"}}